{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:15:31Z","timestamp":1769156131113,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Penn Center for AIDS Research","award":["P30 AI 045008"],"award-info":[{"award-number":["P30 AI 045008"]}]},{"name":"Penn Center for AIDS Research","award":["P30 AI 045008"],"award-info":[{"award-number":["P30 AI 045008"]}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["K01TW011481"],"award-info":[{"award-number":["K01TW011481"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>HIV, cancer, and their respective treatments are independently associated with cardiovascular risk, but limited data exist on the intersection of these conditions. The purpose of this study was to gain insights into the cardiovascular risk factor burden and cardiac function in people with HIV (PWH) treated for breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a cohort of PWH and breast cancer treated with anthracyclines and\/or trastuzumab (2017\u20132022) in Botswana, we assessed pre-treatment (baseline) left ventricular ejection fraction (LVEF), and prospectively obtained an echocardiogram at least one year after cancer treatment initiation. Wilcoxon signed rank sum test was used to test the differences between baseline and follow-up LVEF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty-three women were enrolled at a median of 2.1 years (Quartile (Q)1-Q3 1.8\u20133.1) from their cancer treatment initiation. The median age was 48.0 years (Q1-Q3 44.0\u201354.0). All but one patient was on antiretroviral therapy (ART); the median ART duration was 11.6 years (Q1-Q3 6.3\u201315 years) with a median viral load of 30 (Q1-Q3 0\u201330) and CD4 count of 874 (Q1-Q3 361\u20131131). At baseline, 70% were obese or overweight, and 24.2% reported hypertension; this increased to 30.3% at follow-up. The median LVEF at baseline was 65% (Q1-Q3 60\u201368%), and decreased to 62% (Q1-Q3 59\u201365%) at follow-up; an absolute difference of 2.9%, 95%CI: -5.3 to -0.2% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.038). There was no report of clinical heart failure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Obesity and hypertension are highly prevalent amongst PWH and breast cancer. We also noted a statistically significant, but modest decline in LVEF after cancer therapy initiation. Further studies are needed to prospectively characterize the cardiovascular risk factor burden and changes in cardiac structure and function following cardiotoxic cancer treatment in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40959-025-00417-3","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:01:49Z","timestamp":1769101309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular risk factors and cardiac dysfunction in people with HIV and breast cancer: an observational cohort study in Botswana"],"prefix":"10.1186","volume":"12","author":[{"given":"Henrietta","family":"Afari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congying","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Mwita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thato","family":"Moshomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anran","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maliha","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebaga W.","family":"Motlhwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tlotlo","family":"Ralefala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Vuylsteke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Dryden-Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla Y.","family":"Hsue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mosepele","family":"Mosepele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Ky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehoda M.","family":"Martei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"417_CR1","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S2666-7568(22)00041-1","volume":"3","author":"The Lancet Healthy Longevity null","year":"2022","unstructured":"The Lancet Healthy Longevity null. Ageing with HIV. Lancet Healthy Longev. 2022;3:e119.","journal-title":"Lancet Healthy Longev"},{"issue":"Suppl 1","key":"417_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/QAD.0b013e3283560f54","volume":"26","author":"J Negin","year":"2012","unstructured":"Negin J, B\u00e4rnighausen T, Lundgren JD, Mills EJ. Aging with HIV in africa: the challenges of living longer. AIDS Lond Engl. 2012;26(Suppl 1):S1\u20135.","journal-title":"AIDS Lond Engl"},{"key":"417_CR3","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","volume":"33","author":"AE Coghill","year":"2015","unstructured":"Coghill AE, Shiels MS, Suneja G, Engels EA. Elevated cancer-specific mortality among HIV-infected patients in the united States. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33:2376\u201383.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"417_CR4","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","volume":"138","author":"ASV Shah","year":"2018","unstructured":"Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation. 2018;138:1100\u201312.","journal-title":"Circulation"},{"key":"417_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012241","volume":"8","author":"A Alonso","year":"2019","unstructured":"Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database. J Am Heart Assoc. 2019;8:e012241.","journal-title":"J Am Heart Assoc"},{"key":"417_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(23)00285-4","volume":"401","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2023","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk, early breast cancer trialists\u2019 collaborative group (EBCTCG). Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100\u2008000 women from 86 randomised trials. Lancet Lond Engl. 2023;401:1277\u201392.","journal-title":"Lancet Lond Engl"},{"key":"417_CR7","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.116.023463","volume":"135","author":"HK Narayan","year":"2017","unstructured":"Narayan HK, Finkelman B, French B, Plappert T, Hyman D, Smith AM, et al. Detailed echocardiographic phenotyping in breast cancer patients: associations with ejection fraction decline, recovery, and heart failure symptoms over 3 years of follow-up. Circulation. 2017;135:1397\u2013412.","journal-title":"Circulation"},{"key":"417_CR8","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jcmg.2015.11.024","volume":"9","author":"HK Narayan","year":"2016","unstructured":"Narayan HK, French B, Khan AM, Plappert T, Hyman D, Bajulaiye A, et al. Noninvasive measures of ventricular-arterial coupling and circumferential strain predict cancer therapeutics-related cardiac dysfunction. JACC Cardiovasc Imaging. 2016;9:1131\u201341.","journal-title":"JACC Cardiovasc Imaging"},{"key":"417_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35:893\u2013911.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"417_CR10","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.jacc.2012.07.068","volume":"60","author":"J Chen","year":"2012","unstructured":"Chen J, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP. Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Coll Cardiol. 2012;60:2504\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"417_CR11","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1016\/S2352-3018(21)00326-X","volume":"9","author":"S Chasimpha","year":"2022","unstructured":"Chasimpha S, McCormack V, Cubasch H, Joffe M, Zietsman A, Galukande M, et al. Disparities in breast cancer survival between women with and without HIV across sub-Saharan Africa (ABC-DO): a prospective, cohort study. Lancet HIV. 2022;9:e160\u201371.","journal-title":"Lancet HIV"},{"key":"417_CR12","doi-asserted-by":"publisher","first-page":"e2200016","DOI":"10.1200\/GO.22.00016","volume":"8","author":"YM Martei","year":"2022","unstructured":"Martei YM, Narasimhamurthy M, Setlhako DI, Ayane G, Ralefala T, Chiyapo S, et al. Relative dose intensity and pathologic response rates in patients with breast cancer and with and without HIV who received neoadjuvant chemotherapy. JCO Glob Oncol. 2022;8:e2200016.","journal-title":"JCO Glob Oncol"},{"issue":"4","key":"417_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2016;29(4):277\u2013314.","journal-title":"J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr"},{"key":"417_CR14","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the Prevention, Detection, Evaluation, and management of high blood pressure in adults: A report of the American college of Cardiology\/American heart association task force on clinical practice guidelines. Hypertens Dallas Tex 1979. 2018;71:e13\u2013115.","journal-title":"Hypertens Dallas Tex 1979"},{"key":"417_CR15","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international Cardio-Oncology society (IC-OS). Eur Heart J. 2022;43:4229\u2013361.","journal-title":"Eur Heart J"},{"key":"417_CR16","doi-asserted-by":"publisher","first-page":"17814","DOI":"10.1038\/s41598-023-44499-4","volume":"13","author":"M Mosepele","year":"2023","unstructured":"Mosepele M, Bennett K, Gaolathe T, Makhema JM, Mmalane M, Holme MP, et al. Prevalence and control of hypertension in a high HIV-prevalence setting, insights from a population based study in Botswana. Sci Rep. 2023;13:17814.","journal-title":"Sci Rep"},{"key":"417_CR17","first-page":"e46","volume":"80","author":"JB Cohen","year":"2023","unstructured":"Cohen JB, Brown NJ, Brown S-A, Dent S, van Dorst DCH, Herrmann SM, et al. Cancer Therapy-Related hypertension: A scientific statement from the American heart association. Hypertens Dallas Tex 1979. 2023;80:e46\u201357.","journal-title":"Hypertens Dallas Tex 1979"},{"key":"417_CR18","doi-asserted-by":"publisher","DOI":"10.4081\/jphia.2023.2068","volume":"14","author":"Z Janse Van Rensburg","year":"2023","unstructured":"Janse Van Rensburg Z, Vincent-Lambert C, Razlog R, Phaladze N. Prevalence of hypertension in a sample of community members in a low-income peri-urban setting in Gaborone, Botswana. J Public Health Afr. 2023;14:2068.","journal-title":"J Public Health Afr"},{"key":"417_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000665","volume":"3","author":"VS Hahn","year":"2014","unstructured":"Hahn VS, Lenihan DJ, Ky B. Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies. J Am Heart Assoc. 2014;3:e000665.","journal-title":"J Am Heart Assoc"},{"key":"417_CR20","first-page":"205","volume":"59","author":"SY Jung","year":"2012","unstructured":"Jung SY, Rosenzweig M, Linkov F, Brufsky A, Weissfeld JL, Sereika SM. Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancer. Hypertens Dallas Tex 1979. 2012;59:205\u201311.","journal-title":"Hypertens Dallas Tex 1979"},{"key":"417_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/CIRCHEARTFAILURE.109.854943","volume":"3","author":"PY Hsue","year":"2010","unstructured":"Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, et al. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail. 2010;3:132\u20139.","journal-title":"Circ Heart Fail"},{"issue":"8","key":"417_CR22","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jcmg.2018.01.015","volume":"11","author":"KW Zhang","year":"2018","unstructured":"Zhang KW, Finkelman BS, Gulati G, et al. Abnormalities in 3-dimensional left ventricular mechanics with anthracycline chemotherapy are associated with systolic and diastolic dysfunction. JACC Cardiovasc Imaging. 2018;11(8):1059\u201368.","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00417-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-025-00417-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00417-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:01:50Z","timestamp":1769101310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-025-00417-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1186\/s40959-025-00417-3","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}